Olmesartan (Benicar) for hypertension
Olmesartan medoxomil (Benicar - Sankyo), a substituted imidazole, is the seventh oral angiotensin II receptor blocker (ARB) approved by the FDA for treatment of hypertension....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Olmesartan (Benicar) for hypertension
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1136
Article Code: 1136b
Date: August 5, 2002
Volume: 44
Pages: 69-70
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1136
Article Code: 1136b
Date: August 5, 2002
Volume: 44
Pages: 69-70
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)